{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:04:03Z","timestamp":1773961443615,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejphar.2019.04.035","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T11:06:35Z","timestamp":1556017595000},"page":"240-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["An anti-PLVAP antibody suppresses laser-induced choroidal neovascularization in monkeys"],"prefix":"10.1016","volume":"854","author":[{"given":"Yasuhiro","family":"Nakagami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.04.035_bib1","first-page":"2355","article-title":"Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration","volume":"9","author":"Balaratnasingam","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib2","doi-asserted-by":"crossref","first-page":"C267","DOI":"10.1152\/ajpcell.00138.2011","article-title":"Angiotensin II increases the permeability and PV-1 expression of endothelial cells","volume":"302","author":"Bodor","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12987-018-0109-2","article-title":"The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema","volume":"15","author":"Bosma","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ejphar.2019.04.035_bib4","first-page":"CD007325","article-title":"Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion","volume":"5","author":"Braithwaite","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2019.04.035_bib5","doi-asserted-by":"crossref","first-page":"7643","DOI":"10.1158\/1078-0432.CCR-05-1099","article-title":"Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis","volume":"11","author":"Carson-Walter","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.04.035_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40259-018-0322-1","article-title":"Comparative effectiveness and safety of monoclonal antibodies (bevacizumab, cetuximab, and panitumumab) in combination with chemotherapy for metastatic colorectal cancer: a systematic review and meta-analysis","volume":"32","author":"da Silva","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejphar.2019.04.035_bib7","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/j.1582-4934.2012.01587.x","article-title":"PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts","volume":"16","author":"Deharvengt","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2019.04.035_bib8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Diabetic Retinopathy Clinical Research Network","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.04.035_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","article-title":"The inner blood-retinal barrier: cellular basis and development","volume":"139","author":"D\u00edaz-Cor\u00e1nguez","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.ejphar.2019.04.035_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/eye.2016.208","article-title":"Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents","volume":"31","author":"Gemenetzi","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.ejphar.2019.04.035_bib11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3892\/etm.2016.3557","article-title":"Plasmalemma vesicle-associated protein: a crucial component of vascular homeostasis","volume":"12","author":"Guo","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2019.04.035_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00418-012-0987-3","article-title":"Lack of endothelial diaphragms in fenestrae and caveolae of mutant Plvap-deficient mice","volume":"138","author":"Herrnberger","year":"2012","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115005","article-title":"Formation of fenestrae in murine liver sinusoids depends on plasmalemma vesicle-associated protein and is required for lipoprotein passage","volume":"9","author":"Herrnberger","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.04.035_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2008-11-188763","article-title":"The prototype endothelial marker PAL-E is a leukocyte trafficking molecule","volume":"114","author":"Keuschnigg","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2019.04.035_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/EB.S94447","article-title":"Revisiting the mouse model of oxygen-induced retinopathy","volume":"8","author":"Kim","year":"2016","journal-title":"Eye Brain"},{"key":"10.1016\/j.ejphar.2019.04.035_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.exer.2009.01.006","article-title":"Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes","volume":"89","author":"Klaassen","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2019.04.035_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejphar.2019.04.035_bib18","article-title":"Animal models of diabetic retinopathy: summary and comparison","volume":"106594","author":"Lai","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2019.04.035_bib19","first-page":"CD008721","article-title":"Anti-vascular endothelial growth factor for proliferative diabetic retinopathy","volume":"11","author":"Martinez-Zapata","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2019.04.035_bib20","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/bph.12999","article-title":"Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits","volume":"172","author":"Nakagami","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archophthalmol.2011.210","article-title":"Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates","volume":"129","author":"Nork","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphar.2015.00248","article-title":"Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach","volume":"6","author":"Platania","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcp.2018.09.016","article-title":"Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy","volume":"158","author":"Platania","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14665","article-title":"Retinal and circulating miRNA expression patterns in diabetic retinopathy: an in silico and in vivo approach","author":"Platania","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ni.3101","article-title":"The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes","volume":"16","author":"Rantakari","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature19814","article-title":"Fetal liver endothelium regulates the seeding of tissue-resident macrophages","volume":"538","author":"Rantakari","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.04.035_bib27","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.2741\/3587","article-title":"Settings and mechanisms for trans-cellular diapedesis","volume":"14","author":"Sage","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)."},{"key":"10.1016\/j.ejphar.2019.04.035_bib28","first-page":"CD009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2019.04.035_bib29","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s001250051200","article-title":"Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage","volume":"42","author":"Schlingemann","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.04.035_bib30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/1389200216666151001120831","article-title":"Pharmacokinetic and pharmacodynamic properties of anti-VEGF drugs after intravitreal injection","volume":"16","author":"Semeraro","year":"2015","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib31","first-page":"CD005139","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"3","author":"Solomon","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2019.04.035_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1582-4934.2007.00075.x","article-title":"Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis","volume":"11","author":"Stan","year":"2007","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2019.04.035_bib33","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1073\/pnas.96.23.13203","article-title":"PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia","volume":"96","author":"Stan","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2019.04.035_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/geno.2000.6489","article-title":"cDNA and protein sequence, genomic organization, and analysis of cis regulatory elements of mouse and human PLVAP genes","volume":"72","author":"Stan","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.ejphar.2019.04.035_bib35","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.devcel.2012.11.003","article-title":"The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition","volume":"23","author":"Stan","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2019.04.035_bib36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/path.1805","article-title":"Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF)","volume":"206","author":"Strickland","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0030-1253447","article-title":"Morphological heterogeneity of endothelium","volume":"36","author":"Tse","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ejphar.2019.04.035_bib38","first-page":"CD007419","article-title":"Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis","volume":"6","author":"Virgili","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2019.04.035_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-\u03b2 signalling","volume":"499","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2019.04.035_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exer.2014.03.005","article-title":"Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy","volume":"122","author":"Wisniewska-Kruk","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2019.04.035_bib41","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajpath.2015.11.019","article-title":"Plasmalemma vesicle-associated protein has a key role in blood-retinal barrier loss","volume":"186","author":"Wisniewska-Kruk","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2019.04.035_bib42","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/j.1600-6143.2007.01876.x","article-title":"Glomerular expression of plasmalemmal vesicle-associated protein-1 in patients with transplant glomerulopathy","volume":"7","author":"Yamamoto","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ejphar.2019.04.035_bib43","article-title":"The efficacy and safety of current treatments in diabetic macular edema: a systematic review and network meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919302699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:28:42Z","timestamp":1757975322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919302699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":43,"alternative-id":["S0014299919302699"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.04.035","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An anti-PLVAP antibody suppresses laser-induced choroidal neovascularization in monkeys","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}